JRJRQ yields 2000000.00% · PFE yields 6.13%● Live data
📍 JRJRQ pulled ahead of the other in Year 1
Combined, JRJRQ + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JRJRQ + PFE for your $10,000?
JRjr33, Inc., together with its subsidiaries, operates direct-to-consumer brands in the United States and internationally. It operates three segments: home décor, nutritional and wellness, and gourmet food. The company offers hand-crafted baskets and a line of products for the home, including pottery, cleaning, beauty, outdoor, customizable vinyl expressions for display, wrought iron, and fabric accessories; hand-crafted spices, oils, dip mixes, dukkahs, baking mixes, vinegars, and other food products; and nutritional supplements and skin care products. It also publishes a monthly magazine, as well as provides stationery and paper gifts; tools for women; and health and beauty products, electricals, housewares, Christmas products, toys, gifts, garden products, and personalized gifts. JRjr33, Inc. sells its products directly to customers, as well as through independent sales representatives, Internet, mail, telephone, and fax. JRjr33, Inc. was formerly known as CVSL Inc. and changed its name to JRjr33, Inc. in March 2016. JRjr33, Inc. is based in Dallas, Texas. On October 26, 2018, the voluntary petition of JRjr33, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on June 29, 2018.
Full JRJRQ Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.